Re: Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients with High-risk Prostate Cancer with Rising Prostate-specific Antigen Levels After Primary Local Therapy A Randomized Clinical Trial
Publication date: Available online 12 April 2019Source: European UrologyAuthor(s): Alexander Kretschmer, Derya Tilki
Source: European Urology - Category: Urology & Nephrology Source Type: research
More News: Cancer | Cancer & Oncology | Clinical Trials | Docetaxel | Prostate Cancer | Taxotere | Urology & Nephrology